FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
CEO of short target Exact Sciences (NASDAQ: EXAS) will be on CNBC's Mad Money with Jim Cramer tonight.
... MoreCanaccord Genuity raised its price target on Exact Sciences (NASDAQ: EXAS) to $40.00 (from $38.00) while maintaining a Buy rating, following news UnitedHealthcare will add Cologuard to commercial coverage.
Analyst Mark Massaro notes expectations for UnitedHealthcare to add roughly 30 million covered lives for... More

